Inventor · disambiguated record
Ronald Jay Hinklin
Also filed as: HINKLIN RONALD J · HINKLIN RONALD JAY
31 granted patents·11 pending applications·143 citations·filing 2003–2024
96Inventor score
Files withARRAY BIOPHARMA INC21AICHER THOMAS DANIEL7LILLY CO ELI5MIRATI THERAPEUTICS INC3DODGE JEFFREY ALAN2
Top patents by PatentIndex Score
42 records- 0196US10125134B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·43 cites·9 claims
- 0293US10633381B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·8 cites·7 claims
- 0391US11267812B2KRAS G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·11 cites·34 claims
- 0489US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 0589US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 0689US6974884B2Chemical synthesis of reagents for peptide couplingWISCONSIN ALUMNI RES FOUND·Filed 2003·Granted Dec 13, 2005·22 cites·21 claims
- 0788US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 0888US7317129B2Chemical synthesis of reagents for peptide couplingWISCONSIN ALUMNI RES FOUND·Filed 2005·Granted Jan 8, 2008·10 cites·28 claims
- 0987US8217032B2Selective estrogen receptor modulators for the treatment of vasomotor symptomsDALLY ROBERT DEAN·Filed 2011·Granted Jul 10, 2012·15 cites·14 claims
- 1087US8022222B2Glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·7 cites·16 claims
- 1184US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 1283US8022223B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·5 cites·20 claims
- 1381US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 1480US7713979B2Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2005·Granted May 11, 2010·4 cites·7 claims
- 1579US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1678US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 1778US2024174666A1PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASESARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1876US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1975US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 2075US8362037B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2008·Granted Jan 29, 2013·2 cites·23 claims
- 2174US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 2269US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 2364US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 2463US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 2560US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 2655US8883828B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 11, 2014·0 cites·11 claims
- 2755US8431713B22-aminopyridine derivatives as glucokinase activatorsAICHER THOMAS DANIEL·Filed 2008·Granted Apr 30, 2013·0 cites·2 claims
- 2852US8354540B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2011·Granted Jan 15, 2013·0 cites·18 claims
- 2949US2020216416A1Quinoline compounds as inhibitors of tam and met kinasesARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3049US2009023917A1Selective Estrogen Receptor Modulators for the Treatment of Vasomotor SymptomsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 3146US7271264B2Pentacyclic oxepines and derivatives thereof, compositions and methodsLILLY CO ELI·Filed 2003·Granted Sep 18, 2007·0 cites·34 claims
- 3244US8088776B2Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1AICHER THOMAS DANIEL·Filed 2007·Granted Jan 3, 2012·0 cites·20 claims
- 3344US7834194B2Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2005·Granted Nov 16, 2010·0 cites·4 claims
- 3443US8476300B2Selective estrogen receptor modulator for the treatment of osteoarthritisDODGE JEFFREY ALAN·Filed 2009·Granted Jul 2, 2013·0 cites·14 claims
- 3543US2010184764A1Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2010·Application pending·0 cites
- 3642US8933077B2Glucokinase activatorsAICHER THOMAS D·Filed 2006·Granted Jan 13, 2015·0 cites·16 claims
- 3742US2014309226A1Piperidinyl-substituted cyclic ureas as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3841US2014256756A1Piperidinyl-substituted lactams as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3939US2008214621A1Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1AICHER THOMAS DANIEL·Filed 2005·Application pending·0 cites
- 4038US2013184257A1Piperidinyl-substituted lactams as gpr119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Application pending·0 cites
- 4137US8754226B2Piperidinyl-substituted lactams as GPR119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Granted Jun 17, 2014·0 cites·71 claims
- 4234US2008227814A1Selective Estrogen Receptor ModulatorsDODGE JEFFREY ALAN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →